Michele Follen

Title: Michele Follen: Innovator in HPV Research

Introduction

Michele Follen is a prominent inventor based in Houston, TX (US), known for his significant contributions to the field of medical research, particularly in relation to human papillomavirus (HPV). With a total of 5 patents, Follen has made strides in developing methods and compositions that address HPV-associated pre-cancerous and cancerous growths.

Latest Patents

Follen's latest patents focus on innovative methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including cervical intraepithelial neoplasia (CIN). His inventions concern the use of E6 and/or E7 peptides from HPV to evaluate a cell-mediated response in patients infected with the virus. This evaluation is crucial for determining the prognosis for patients regarding the development or recurrence of pre-cancerous or cancerous growths.

Career Highlights

Throughout his career, Michele Follen has worked with the University of Texas System, where he has contributed to advancing research in HPV and its implications for cancer. His work has been instrumental in enhancing the understanding of HPV-related health issues and developing potential therapeutic approaches.

Collaborations

Follen has collaborated with notable colleagues, including Urs Utzinger and Rebecca Rae Richards-Kortum, who have also made significant contributions to the field of medical research. Their combined efforts have fostered advancements in understanding and treating HPV-related conditions.

Conclusion

Michele Follen's innovative work in HPV research has led to important advancements in the understanding and treatment of HPV-associated conditions. His contributions continue to impact the medical field positively, paving the way for future research and developments.